IL126983A0 - Growth hormone components and bone anti-resorptive agent in cyclic (coherence) treatment of osteoporosis - Google Patents

Growth hormone components and bone anti-resorptive agent in cyclic (coherence) treatment of osteoporosis

Info

Publication number
IL126983A0
IL126983A0 IL12698397A IL12698397A IL126983A0 IL 126983 A0 IL126983 A0 IL 126983A0 IL 12698397 A IL12698397 A IL 12698397A IL 12698397 A IL12698397 A IL 12698397A IL 126983 A0 IL126983 A0 IL 126983A0
Authority
IL
Israel
Prior art keywords
osteoporosis
coherence
cyclic
treatment
growth hormone
Prior art date
Application number
IL12698397A
Other languages
English (en)
Original Assignee
Novo Nordisk As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novo Nordisk As filed Critical Novo Nordisk As
Publication of IL126983A0 publication Critical patent/IL126983A0/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/02—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
    • C07K5/0207—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing the structure -NH-(X)4-C(=0), e.g. 'isosters', replacing two amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/27—Growth hormone [GH] (Somatotropin)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
IL12698397A 1996-05-31 1997-05-29 Growth hormone components and bone anti-resorptive agent in cyclic (coherence) treatment of osteoporosis IL126983A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DK62396 1996-05-31
PCT/DK1997/000239 WO1997046252A1 (en) 1996-05-31 1997-05-29 Growth hormone component and bone anti-resorptive agent in cyclic (coherence) treatment of osteoporosis

Publications (1)

Publication Number Publication Date
IL126983A0 true IL126983A0 (en) 1999-09-22

Family

ID=8095682

Family Applications (1)

Application Number Title Priority Date Filing Date
IL12698397A IL126983A0 (en) 1996-05-31 1997-05-29 Growth hormone components and bone anti-resorptive agent in cyclic (coherence) treatment of osteoporosis

Country Status (14)

Country Link
EP (1) EP0907374A1 (xx)
JP (1) JP2000512274A (xx)
KR (1) KR20000016204A (xx)
CN (1) CN1220609A (xx)
AU (1) AU3025997A (xx)
BR (1) BR9709499A (xx)
CA (1) CA2257174A1 (xx)
CZ (1) CZ383298A3 (xx)
HU (1) HUP9904049A3 (xx)
IL (1) IL126983A0 (xx)
NO (1) NO985573L (xx)
PL (1) PL330239A1 (xx)
WO (1) WO1997046252A1 (xx)
ZA (1) ZA974785B (xx)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HN1996000101A (es) 1996-02-28 1997-06-26 Inc Pfizer Terapia combinada para la osteoporosis
GB2324726A (en) * 1997-05-01 1998-11-04 Merck & Co Inc Combination Therapy for the Treatment of Osteoporosis
WO1999064456A1 (en) * 1998-06-09 1999-12-16 Novo Nordisk A/S A method for preparing a compound with growth hormone releasing properties
US6784158B1 (en) 1998-06-09 2004-08-31 Novo Nordisk A/S Method for preparing a compound with growth hormone releasing properties
JP2001031635A (ja) 1999-07-14 2001-02-06 Ajinomoto Co Inc 光学活性ｎ−保護−ｎ−メチル−フェニルアラニン誘導体の製造方法
EP1159964B1 (en) 2000-05-31 2009-10-28 Pfizer Products Inc. Use of growth hormone secretagogues for stimulating gastrointestinal motility
US7476653B2 (en) 2003-06-18 2009-01-13 Tranzyme Pharma, Inc. Macrocyclic modulators of the ghrelin receptor
CU23558A1 (es) 2006-02-28 2010-07-20 Ct Ingenieria Genetica Biotech Compuestos análogos a los secretagogos peptidicos de la hormona de crecimiento
BRPI0807046A2 (pt) 2007-02-09 2015-05-26 Tranzyme Pharma Inc Composto, composição farmacêutica, métodos de tratar um distúrbio, uma doença cardiovascular e um paciente que sofre de motilidade gastrointestinal reduzida ou disfuncional e, kit.

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ236618A (en) * 1990-01-03 1997-06-24 Ciba Geigy Ag Treating and preventing osteoporosis using insulin-like growth factor i (igf i) in conjunction with a bone antiresorptive active compound
ATE150648T1 (de) * 1990-11-26 1997-04-15 Robert R Recker Behandlung von osteoporose unter verwendung von wachstumshormon-freisetzendem faktor (grf) in verbindung mit parathyroidhormon (pth)
WO1995011029A1 (en) * 1993-10-19 1995-04-27 Merck & Co., Inc. Combination of bisphosphonates and growth hormone secretagogues

Also Published As

Publication number Publication date
BR9709499A (pt) 1999-08-10
HUP9904049A3 (en) 2000-07-28
AU3025997A (en) 1998-01-05
PL330239A1 (en) 1999-05-10
KR20000016204A (ko) 2000-03-25
HUP9904049A2 (hu) 2000-04-28
CN1220609A (zh) 1999-06-23
WO1997046252A1 (en) 1997-12-11
NO985573D0 (no) 1998-11-27
EP0907374A1 (en) 1999-04-14
NO985573L (no) 1999-01-29
CA2257174A1 (en) 1997-12-11
JP2000512274A (ja) 2000-09-19
CZ383298A3 (cs) 1999-07-14
ZA974785B (en) 1998-01-22

Similar Documents

Publication Publication Date Title
EP0767624A4 (en) DEVICES AND METHOD FOR PREPARING BONE / TISSUE
ZA9510147B (en) Hard tissue bone cements and substitutes
AU3021897A (en) Bone prosthesis fixation device and methods of using same
IL133864A0 (en) Combination distraction dental implant and method of use
HK1030545A1 (en) Use of parathyroide hormone consisting of aminoacid sequence 1-34 of human parathyroid hormone for reducing the risk of both vertebral and non vertebral bone fracture
PL339449A1 (en) Treatment of bone fractures involving the use of pthrp analogues
EP0480579A3 (en) Method and apparatus for the fixation of bone fractures, limb lengthening and the correction of deformities
EP0675700A4 (en) APPARATUS AND METHOD FOR FIXING LONG BONES AND TREATING SPINAL DISORDERS.
AU1917295A (en) Bone and tissue lengthening device
EP0741548A4 (en) DEVICE AND METHOD FOR REAR SPINE FIXATION
AU5799099A (en) Method and devices for use in bone fixation procedures
IL143645A0 (en) Improved device for the external fixation of bone fractures, in particular ankle fractures
HU9401798D0 (en) Methods for the treatment of osteoporosis using bisphonates and parathyroid hormone
PL328831A1 (en) Combined treatment of osteoporosis
ZA953006B (en) Human bone stimulating factor
ZA9810247B (en) Improved apparatus and method for micro-abrasions of human tissue and/or hides
IL126983A0 (en) Growth hormone components and bone anti-resorptive agent in cyclic (coherence) treatment of osteoporosis
EP0424159A3 (en) Aseptic processing of allograft bone and tissue
MX9703944A (es) Metodo para usar derivados de triaril-etileno en el tratamiento y prevencion de osteoporosis.
GB9421362D0 (en) Orthopaedic human bone demonstational aid
GB9321341D0 (en) Therapeutic compositions for use in the treatment of skin lesions and method of making same
EP0779812A4 (en) METHOD FOR TREATING OSTEOPOROSIS USING BONE-ACTIVE PHOSPHONATES AND PARATHORMONE
EP1009433A4 (en) THERAPEUTIC COMPOSITION AND TREATMENT METHOD
ZA958277B (en) The fixation of long bone fractures
IL114063A0 (en) Solution comprising IGF-I or any functional analogue thereof and method for its preparation